Cargando…
A Novel Platform for the Potentiation of Therapeutic Antibodies Based on Antigen-Dependent Formation of IgG Hexamers at the Cell Surface
IgG antibodies can organize into ordered hexamers on cell surfaces after binding their antigen. These hexamers bind the first component of complement C1 inducing complement-dependent target cell killing. Here, we translated this natural concept into a novel technology platform (HexaBody technology)...
Autores principales: | de Jong, Rob N., Beurskens, Frank J., Verploegen, Sandra, Strumane, Kristin, van Kampen, Muriel D., Voorhorst, Marleen, Horstman, Wendy, Engelberts, Patrick J., Oostindie, Simone C., Wang, Guanbo, Heck, Albert J. R., Schuurman, Janine, Parren, Paul W. H. I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703389/ https://www.ncbi.nlm.nih.gov/pubmed/26736041 http://dx.doi.org/10.1371/journal.pbio.1002344 |
Ejemplares similares
-
Staphylococcal protein A inhibits complement activation by interfering with IgG hexamer formation
por: Cruz, Ana Rita, et al.
Publicado: (2021) -
Human IgG is produced in a pro-form that requires clipping of C-terminal lysines for maximal complement activation
por: van den Bremer, Ewald TJ, et al.
Publicado: (2015) -
Carbamylation reduces the capacity of IgG for hexamerization and complement activation
por: Lubbers, R., et al.
Publicado: (2020) -
Mutation of Y407 in the CH3 domain dramatically alters glycosylation and structure of human IgG
por: Rose, Rebecca J., et al.
Publicado: (2013) -
Avidity in antibody effector functions and biotherapeutic drug design
por: Oostindie, Simone C., et al.
Publicado: (2022)